Atlas Trials

This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.

Clinical trial NCT07649122 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07649122
Sponsor
Norroy Bioscience Co., LTD
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2026-06-30
Primary completion
2028-06-30
Enrollment
232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.